Skip to search formSkip to main contentSkip to account menu

AA 673

Known as: AA-673 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
A single-blind study with envelopes of AA-673 for nebulization was conducted to assess its efficacy and to establish the proper… 
1990
1990
The pharmacodynamics of Amlexanox (AA-673), an azoxanthone derivative recently developed as an ocular anti-allergic drug, were… 
1989
1989
The effect of amlexanox on the non-immunological or immunological release of histamine or leukotrienes (LTs) from passively… 
1989
1989
The inhibitory effect of 0.25% AA-673 eye drops on histamine release in tears was examined by an ocular provocation test with… 
1989
1989
The influences of anti-allergic drugs on superoxide generation from the hypoxanthine-xanthine oxidase system or polymorphonuclear… 
1989
1989
The therapeutic effects and safety of AA-673 tablets were studied in 54 patients with perennial nasal allergy refractory to other… 
1988
1988
Twenty patients with perennial allergic rhinitis were treated with AA-673 tablets for a mean period of 66 days.Based on the final…